Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Dermira, Inc.
3129
Dermira, Inc.
Technology
Biotechnology
Dermira is a development-stage biotech company focused on developing andcommercializing innovative new therapies in dermatology.
Suggest edits
Founded
2010
Raised
$129.5M
Follow us
Also headquartered in Menlo Park
Facebook
Andreessen Horowitz
Sequoia Capital
Kleiner Perkins
Silver Lake
NEA
Lightspeed Venture Partners
Lucid Motors
Parse
Mayfield
Companies in the same industry
AudentesTherapeutics
Stemgent
Proteostasis Therapeutics, Inc.
Schrödinger
Western Technology Investment
ProteinSimple
Takeda Pharmaceutical Company Ltd
Savara Pharmaceuticals
Bausch + Lomb
Richard Pops
Alexa global traffic share
Overview
Funding
4
Add info
Acquired by
2
10 Jan 2020
Eli Lilly and Co
Latest funding
Show all
$1,500,000
Post-IPO equity - 2016
$51,000,000
Venture capital (Series C) - 2014
Canaan Partners
Aisling Capital
NEA
+5
Location
Menlo Park
,
United States
Headquarters
Explore Menlo Park
Acquisition
Xconomy
,
FinSMEs
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira
Bloomberg
Dermira Reminds Investors What Binary Means in Biotech
Stock markets
Health
Xconomy
Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters
Health
Xconomy
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Health
